drugset / Trial / NCT03378973

The Effects of Dexmedetomidine Dose on Motor Evoked Potentials

NCT03378973 ↗

Phase 4 Terminated 7 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupSingle-blindOther

Summary

This a parallel group, two-arm, randomized superiority trial that will compare the effect of two different doses of dexmedetomidine on motor evoked potentials during spine surgery

Timeline

Start
2018-11-28
Primary completion
2019-10-17
Completion
2019-10-17

Outcome

Outcome not reported

Stopped: “No longer clinically relevant”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Subject Dexmedetomidine Other / unclassified 1 ug/kg —

Indications

No indication recorded.